Raab & Moskowitz Asset Management’s VanEck Biotech ETF BBH Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-106	Closed	-$14K	–	166
2019 Q4	$14K	Buy	+106	New	+$13.9K	0.01%	367
2018 Q4	–	Sell	-134	Closed	-$18K	–	186
2018 Q3	$18K	Buy	+134	New	+$17.4K	0.01%	360

Other funds holding BBH

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Raab & Moskowitz Asset Management's BBH Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of VanEck Biotech ETF (BBH) in Q1 2020, closing a stake of 106 shares — an estimated $14K sold.

Raab & Moskowitz Asset Management first reported a position in BBH in Q3 2018 and held it in 2 quarters. The position peaked at $18K in Q3 2018. 83 funds tracked by Wall St. Rank hold BBH as of Q1 2020.

Raab & Moskowitz Asset Management reported no remaining VanEck Biotech ETF position as of Q1 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 106 VanEck Biotech ETF shares in Q1 2020, an estimated $14K.
Raab & Moskowitz Asset Management first reported a position in VanEck Biotech ETF in Q3 2018 and held it in 2 quarters.
Raab & Moskowitz Asset Management's VanEck Biotech ETF position peaked at $18K in Q3 2018.
83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.